Renk’s Share Price Keeps Falling While Its Order Book Keeps Growing — Now Fund Managers Are Stirring

The gap between how Renk Group performs and how its shares are treated on the market has rarely looked wider. The defence supplier closed Friday at €43.50, a level that leaves the stock barely 7.7 percent above its 52-week low, while its order backlog sits at an all-time high of €7.4 billion. The disconnect is becoming harder to explain away.

That tension is now drawing attention to the company’s shareholder register. Two voting-right notifications landed within days of each other, filed on 2 and 4 September under Section 40 (1) of the German Securities Trading Act (WpHG). The short-form notices do not disclose which thresholds were crossed or in which direction, leaving investors to parse the underlying documents for detail. What is clear is the timing: these disclosures arrive as the stock languishes 52 percent below its October peak of €90.20.

Wellington’s repeated moves

One name has already emerged from the filings. Wellington Management Group LLP reported a change above the 5 percent threshold on 2 September, this time using equity swaps. The disclosure follows a comparable notification from the investor on 28 August, suggesting the asset manager is actively adjusting its position in Renk rather than sitting still.

Whether Wellington is building a stake or trimming one remains unclear from the filings themselves. The repeated disclosures do, however, signal that a major institutional investor continues to engage with the stock despite its weak price action. BlackRock had already touched a 4.44 percent threshold back in June, evidence that large asset managers have not abandoned the name entirely.

The distinction matters for the share price trajectory. Fresh institutional buying would provide a counterweight to the erosion of market confidence; mere reshuffling of existing positions would leave the central question unanswered — why the market continues to ignore the company’s operational progress.

Analysts split on the way forward

The sell-side is not of one mind. MWB Research lifted its rating on the stock to “buy” from “hold” on Friday, keeping its price target at €48. The upgrade drew a modest response, with the shares gaining around 2 percent on the day — a brief respite after a week that saw the stock shed 8.6 percent in seven days.

That upgrade stands in contrast to an earlier mwb Research call from July, when the house downgraded Renk to “hold” with a €50 target. The older assessment has aged, but it shows that at least one analyst had voiced doubts about the stock’s near-term momentum weeks before the current turbulence.

Should investors sell immediately? Or is it worth buying Renk Group?

The €48 target sits comfortably above the current price, implying the research house sees meaningful upside. Whether the market agrees will likely depend on the next set of catalysts.

Record orders, cautious market

The fundamental picture that underpins MWB’s optimism is hard to argue with. First-half order intake reached €1.189 billion, a record and a 29.7 percent increase year on year. The order book climbed to its all-time high of €7.4 billion, while adjusted EBIT grew 10.1 percent to €98.2 million.

Management has confirmed its full-year guidance of more than €1.5 billion in revenue and an EBIT range of €255 million to €285 million, aiming for the upper end. Contract momentum adds further weight: an expanded framework agreement with Rheinmetall for the KF41 Lynx worth around €270 million plus options, a follow-on order from the US Army for the HMPT-800 transmission, and series orders for the Patria TRACKX programme.

The technical picture tells a less encouraging story. The shares trade at €46.90 below their 50-day average and at €52.16 — a 17 percent gap — below their 200-day average, pointing to sustained medium-term downward pressure. Thirty-day volatility of 32 percent suggests the market remains nervous about the name.

Regulatory risk lingers as well. Export restrictions on business with Israel remain a potential drag on guidance, even though no new developments have been reported since 22 August.

What comes next

The next hard catalyst is the third-quarter results, expected in November. The secondary article points to a date of 5 November for the Q3 2026 report. Around the same time, the planned acquisition of David Brown Defence is slated to close in the fourth quarter, subject to regulatory approval — a deal that could add strategic substance if the timetable holds.

Until then, investors are left weighing a record order book against a share price that keeps sliding. The full GlobeNewswire documents behind the recent voting-right notifications should shed light on whether Wellington and others are accumulating or merely repositioning. For now, the stock sits at the intersection of solid fundamentals, cautious analyst sentiment, and institutional activity that could go either way.